4-(pyridin-4-yl)-1H-(1, 3, 5)triazin-2-one derivatives as GSK3-beta inhibitors for the treatment of neurodegenerative diseases

Details for Australian Patent Application No. 2009263846 (hide)

Owner SANOFI-AVENTIS MITSUBISHI TANABE PHARMA CORPORATION

Inventors Yaiche, Philippe; Saady, Mourad; Lochead, Alistair

Agent A J Park

Pub. Number AU-A-2009263846

PCT Pub. Number WO2009/156860

Priority 08 290 617.3 26.06.08 EP

Filing date 25 June 2009

Wipo publication date 30 December 2009

International Classifications

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/53 (2006.01) - having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

A61P 33/06 (2006.01) Antiparasitic agents

A61P 35/00 (2006.01) Antineoplastic agents

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

Event Publications

20 January 2011 PCT application entered the National Phase

  PCT publication WO2009/156860 Priority application(s): WO2009/156860

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009263847-Substituted pyrimidone derivatives

2009263845-Substituted pyrimido (2, 1-a) isoquinolin-4-one derivatives